AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03648541 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Spesolimab
Description: Solution
Study NCT02992106 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Parental questionnaires
Description: We will provide parents with questionnaires depending on the age of their children:~* Children aged 0-6 years old:~  1. Questionnaire on socio-demographic characteristics~ 2. Dutch Eating Behaviour Questionnaire~ 3. Food Frequency Questionnaire~ 4. Ages and Stages Questionnaire~ 5. Strengths and Difficulties Questionnaire~ 6. Questionnaire on developmental milestones~ 7. Questionnaire on behaviour~* Children older than 6 years:~  1. Questionnaire on socio-demographic characteristics~ 2. Dutch Eating Behaviour Questionnaire~ 3. Food Frequency Questionnaire~ 4. Pediatric Quality of Life Questionnaire~ 5. Children's Behaviour Questionnaire in Dutch~ 6. Questionnaire on developmental milestones~ 7. Developmental Coordination Disorder Questionnaire~ 8. Strengths and Difficulties Questionnaire
Study NCT02286752 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: sugammadex
Description: for reversal of neuromuscular block: sugammadex 2 mg kg-1
Study NCT02992106 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Blood sample
Description: We will determine the following biochemical parameters: glucose, insulin, total cholesterol, LDL, HDL, triglycerides, uric acid, IGF-1, adiponectin, leptin, hs-CRP, IL-6, TNF-α and ICAM-1.
Study NCT02992106 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Urine sample
Description: We will take a urine sample to evaluate the albumin to creatinin ratio.
Study NCT02992106 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Anthropometric measurements
Description: We will measure weight, Height, hip, waist and neck circumference, blood pressure, 4-site skinfold measurements and BIA.
Study NCT02992106 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Ultrasound
Description: We will do an abdominal ultrasound to measure the abdominal fat accumulation
Study NCT02992106 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: EndoPAT
Description: We will use the EndoPAT device to measure endothelial function, which is a non-invasive and innovative technique (peripheral pulse wave amplitude measurement).
Study NCT02992106 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Faces Pain Scale
Description: After performing the measurements with the EndoPAT device, Harpender kalliper and ultrasound, the children will be asked to fill out a Faces Pain Scale, validated for children aged 4-16 years old and obtained for use from the International Association for the Study of Pain
Study NCT03867292 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial
Description: The aim of the application of the crossed hands technique is to produce a deep fascial release, placing the subject in prone position, while the standing physiotherapist will contact with one hand on the spine at the level of the thoracolumbar hinge and with the other hand on the sacrum, so that the hands are crisscrossed. The crossed hands technique will be performed between 90 seconds and 5 minutes.~The application of the TENS, will be performed for 10 minutes by means of a device, model Compex in the lumbar area, subjects will receive a TENS application of low frequency (less than 40Hz). The electrode - (black) in proximal position or on the most painful zone. The electrode + (red) will be placed distally.
Study NCT03867292 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Electrotherapy
Description: The application of the TENS, will be performed for 10 minutes by means of a device, model Compex in the lumbar area, subjects will receive a TENS application of low frequency (less than 40Hz). The electrode - (black) in proximal position or on the most painful zone. The electrode + (red) will be placed distally.
Study NCT01083576 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: WR 279,396 (15% paromomycin + 0.5% gentamicin topical cream)
Description: topical application to CL lesions once daily for 20 days
Study NCT01083576 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paromomycin Alone Cream (15% paromomycin topical cream)
Description: topical application to CL lesions once daily for 20 days
Study NCT02098759 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: epilepsy early diagnosis protocol
Description: Infants that have epileptiform discharges on vEEG and no clinical seizures, if their parents/caregivers give consent, will enter the randomized part of the study. Those children will be randomized into two groups: group A will be diagnosed as having epilepsy after subclinical (electroencephalographic) epileptiform discharges (based on epilepsy early diagnosis protocol), and the patients in group B will be diagnosed as epileptic after clinical seizures appear. All infants diagnosed with epilepsy will receive standard therapy with recommended first line antiepileptic drug starting from the day of diagnosis.
Study NCT02823301 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: VAMOS Program
Description: Active life improving health: all participants that will be assigned to change behavior group will participate of a change behavior program, entitled VAMOS (Active Life Improving Health), for five months. The VAMOS Program is a lifestyle promotion program, that includes physical activity and healthy eating habits. The program is composed by 12 meetings (six weekly meetings and six fortnightly meetings), in group, lasting about 90 min. In each In each weekly meeting, will be discussed guidelines and strategies for physical activities practices in different domains and for adoption of a healthy diet. All aspects and strategies included in the program are based in behavior changes theories.
Study NCT02228629 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CrocsRx Medical Silver cloud clogs
Study NCT03888456 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: osteopathic treatment
Description: the intervention will be based on 2 phases: 1) assessment to identify areas with somatic dysfunction, 2) treatment to improve the function of the area identified
Study NCT03888456 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: osteopathic treatment
Description: the intervention will be based on 2 phases: 1) assessment to identify areas with somatic dysfunction, 2) treatment to improve the function of the area identified
Study NCT03888456 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: sham
Description: the sham intervention will consists of 2 overlapping phases as the intervention group but without applying any technique
Study NCT03888456 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sham
Description: the sham intervention will consists of 2 overlapping phases as the intervention group but without applying any technique
Study NCT03429686 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DRT Intervention
Description: The digital reminiscence therapy intervention will run 12 sessions twice per week, for six weeks, for up to an hour at a time (this will depend on the participant's ability and willingness to participate). The sessions of reminiscence therapy will be culturally appropriate and based on the key stages in the life which most people will have experienced. These sessions are individual, face-to-face sessions.
Study NCT01294631 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg once daily and HCTZ 25 mg once daily
Description: Period 1: canagliflozin tablets, oral, 300 mg, once daily on Days 1 to 7 followed 14 days later by Period 2.~Period 2: HCTZ tablets, oral, 25 mg, once daily for Days 1 to 28 followed by canagliflozin tablets, oral, 300 mg, once daily taken with HCTZ tablets, oral 25 mg, once daily on Days 29 to 35..
Study NCT03125317 — intervention group
Intervention type: OTHER
Intervention: Music
Description: a kind of music which the participant likes will be listened using speakers
Study NCT03125317 — intervention group
Intervention type: OTHER
Intervention: Valsalva maneuver
Description: Participant will be asked to take a deep breath and exhale the air out in 15 seconds
Study NCT03125317 — intervention group
Intervention type: OTHER
Intervention: control
Description: No intervention
Study NCT01561170 — intervention group
Intervention type: DEVICE
Intervention: Active Pulsed Electro-Magnetic Field (PEMF)
Description: One group of patients receive active devices. Both patients and investigator are blinded.
Study NCT01561170 — intervention group
Intervention type: DEVICE
Intervention: Placebo Pulsed Electro-Magnetic Field (PEMF)
Description: One group of patients receive placebo devices. Both patients and investigator are blinded.
Study NCT01864811 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Baby-CIMT
Description: Baby-CIMT is a very much modified model of constraint induced movement therapy for infants. It is developed to suit small children and their needs of stimulation. The infant should wear a comfortable glove on the less affected hand, while stimulating the use of the affected hand 30 minutes per day during 2 periods of 6-weeks training before 12 month. The hand training provides the baby with amusing and easily handled toys.
Study NCT01864811 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Baby-Massage
Description: For baby massage, there will be a special instructional course by a health professional certified for baby massage. Massage should be given every day during 2 periods of 6 weeks. Families will be responsible for the massage.
Study NCT01276353 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E2020
Description: Patients will take study medication orally, once daily, for 2 weeks according to a double-dummy design in the double blind phase: 23 mg donepezil sustained release (SR) concurrently with placebo identical in appearance to the 10 mg donepezil immediate release (IR) formulation
Study NCT01276353 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: E2020
Description: 10 mg donepezil immediate release (IR) concurrently with placebo identical in appearance to the 23 mg donepezil sustained release (SR) formulation. All patients who complete the double blind phase will take 23 mg donepezil sustained release (SR) orally, once daily, for 52 weeks in the Open-label Extension phase.
Study NCT00438984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Description: Given IV
Study NCT00438984 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: therapeutic autologous lymphocytes
Description: Given IV
Study NCT00438984 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: aldesleukin
Description: Given IV or SC
Study NCT00438984 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: immunohistochemistry staining method
Description: Correlative studies
Study NCT00442611 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abatacept
Study NCT00442611 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT04973722 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY06006
Description: 60 mg/1 ml, once every 6 months administered subcutaneously
Study NCT04973722 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prolia
Description: 60 mg/1 ml, once every 6 months administered subcutaneously
Study NCT00618865 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids
Study NCT00618865 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Omega-3 fatty acids
Study NCT04662645 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Palliative Therapy
Description: Undergo embedded palliative care
Study NCT00438984 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: biopsy
Description: Optional correlative studies
Study NCT00438984 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT03380013 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Treatment (OMT)
Description: Each neonate will have a structural exam completed assessing each body region (head, cervical, thoracic, lumbar, sacral, pelvic, rib cage, and abdominal regions) for underlying somatic dysfunctions prior to each treatment. The specific OMT techniques used will be left to the discretion of the treating physician and will not be based on a predetermined protocol. Treatment techniques will consist of myofascial release, balanced ligamentous tension, balanced membranous tension, and osteopathy in the cranial field. Total treatment time will be 15 minutes. The features of the osteopathic structural exam which will be recorded on paper by the treating physician at the time of the evaluation. The paper will be marked only with the research identifier.
Study NCT04256512 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medical Device Usage and Evaluation
Description: Wear Elasto Gel Therapy Mittens and Foot Wraps
Study NCT00438984 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: immunologic technique
Description: Correlative studies
Study NCT00438984 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: polymerase chain reaction
Description: Correlative studies
Study NCT01126450 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lenalidomide
Description: Given orally
Study NCT01126450 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: cetuximab
Description: Given IV
Study NCT01126450 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mutation analysis
Description: Correlative studies
Study NCT01126450 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: polymerase chain reaction
Description: Correlative studies
Study NCT01126450 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: polymorphism analysis
Description: Correlative studies
Study NCT01743053 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standard Care plus ReCell
Study NCT01743053 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard Care
Study NCT02365792 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Clinical Decision Support Tool for Prehospital Care
Description: A clinical decision support system (CDSS) is a health information technology system that is designed to assist physicians and other health professionals with clinical decision-making tasks. A working definition of the Centre for Health Evidence: Clinical Decision Support systems link health observations with health knowledge to influence health choices by clinicians for improved health care.
Study NCT02365792 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Clinical Decision Support Tool for Prehospital Care
Description: A clinical decision support system (CDSS) is a health information technology system that is designed to assist physicians and other health professionals with clinical decision-making tasks. A working definition of the Centre for Health Evidence: Clinical Decision Support systems link health observations with health knowledge to influence health choices by clinicians for improved health care.
Study NCT02761278 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endometrial biopsy
Study NCT03103568 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitisinone in Arm A
Description: 4 capsules of 20 mg nitisinone (80 mg) is given once daily for 17 days.
Study NCT03103568 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tolbutamide
Description: A 500 mg tablet is given as single oral dose 2 weeks apart.
Study NCT03103568 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metoprolol
Description: A 50 mg tablet of metoprolol tartrate is given as single oral dose 2 weeks apart.
Study NCT03103568 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chlorzoxazone
Description: A 250 mg tablet is given as single oral dose 2 weeks apart.
Study NCT03103568 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furosemide
Description: A single intravenous dose of 20 mg administered as an i.v. infusion is given 2 weeks apart.
Study NCT04662645 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT03810053 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile App/Online Module
Description: Short didactic explainer video that will provide information about cancers and benefits of uptake of cancer prevention and early detection measures.
Study NCT03368079 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Negative Pressure Suction Catheter
Description: The negative pressure suction device to be used in the study will be a Foley catheter. The catheter will be placed through the gastrostomy tube site, directed retrograde through the esophagus, and terminating in the PES.
Study NCT01329172 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: polyunsaturated fatty acids n-3
Description: polyunsaturated fatty acids n-3 1 gram per day during two months
Study NCT01329172 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: sun flower oil with Poly Unsaturated Fatty Acid 1g/day
Study NCT03103568 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitisinone in Arm B
Description: 4 capsules of 20 mg nitisinone (80 mg) is given once daily for 16 days.
Study NCT00658450 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation training
Description: A computerised cognitive training package where children will be required to complete several cognitive tasks. The aim is to strengthen the different cognitive processes during these tasks which in turn may lead to improve cognitive processes.~Children will complete these tasks in 16 session for 8 weeks.
Study NCT02150291 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Folic acid
Study NCT04400916 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: A single drop administered topically
Study NCT04400916 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Balanced Salt Solution
Description: A single drop administered topically
Study NCT02150291 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neurobion
Study NCT02150291 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Study NCT04270565 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: In-Field Gait-Training
Description: The intervention will deliver a series of vibrations on the participants' wrists through the Garmin when the sensors indicate that their contact time in milliseconds exceeds a threshold. The runners will be asked to reduce the amount of time their foot is in contact with the ground by picking their feet up more quickly. Participants will also receive a series of exercises based on noted impairments at baseline. The feedback during running will be completed twice per week for four weeks.
Study NCT04270565 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Home Exercise
Description: Participants will receive a series of exercises based on noted impairments at baseline. Exercises will be completed twice per week for four weeks.
Study NCT04270565 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home Exercise
Description: Participants will receive a series of exercises based on noted impairments at baseline. Exercises will be completed twice per week for four weeks.
Study NCT00119769 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo, 0.7 mg/day injected subcutaneously
Study NCT00119769 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Genotropin (human recombinant Growth hormone)
Description: Genotropin, 0.7 mg/day injected subcutaneously
Study NCT03572959 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.1 % topical triamcinolone acetonide
Description: 0.1 % topical triamcinolone acetonide preparation was used where the patients' were instructed to apply the gel 4 times daily, with no food or fluid taken one hour after application.
Study NCT03572959 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SIROIaser
Description: Oral Lichen Planus lesions were irradiated with a 970-nm diode laser with a 2 W irradiation power in a continuous non-contact mode. The laser beam was delivered using a fiber-optic tip with a 320 µm diameter with defocused mode directed at the lesions plus 0.5 cm peri- lesional tissues with a slight overlapping in order to evenly distribute energy covering all the lesional and peri-lesional tissues until blanching of the area was observed.14 Diode laser was calibrated to an output power of 3W, frequency of 30 Hz, energy of 180 joule and time interval of 8 minutes divided into 4 sessions , two min each with one minute rest in between to allow for tissue relaxation.~Irradiation was done twice weekly (once every third day) for two months until the resolution of signs for a maximum of ten sessions.
Study NCT01723046 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Training with new upper limb robot assisted therapy device
Description: During 8 weeks, 3 times a week, 1 hour therapy sessions with the device
Study NCT02810769 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Berry drink
Description: Cold pressed berry drink standardised to contain 500mg of berry polyphenols
Study NCT02810769 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Sugar matched control containing berry flavouring and no phytochemicals
Study NCT02810769 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Powdered berry drink
Description: Berry drink made from a powder concentrate standardised to contain 500mg of polyphenols
Study NCT00856596 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Sertaconazole nitrate cream 2%
Description: Once a day topical cream